共 50 条
- [1] Clinical experiences using radium-223, a novel α-emitting bone-seeking radiopharmaceutical, in breast and prostate cancer patients with skeletal metastasesCANCER TREATMENT REVIEWS, 2005, 31 : S30 - S31Nilsson, SLarsen, RHBruland, OS
- [3] First clinical experience with α-emitting radium-223 in the treatment of skeletal metastasesCLINICAL CANCER RESEARCH, 2005, 11 (12) : 4451 - 4459Nilsson, SLarsen, RHFosså, SDBalteskard, LBorch, KWWestlin, JESalberg, GBruland, OS
- [4] RADIUM REVISITED: CLINICAL EXPERIENCES WITH A NOVEL ALPHA-EMITTING BONE-SEEKING RADIOPHARMACEUTICAL IN PATIENTS WITH SKELETAL METASTASES FROM PROSTATE AND BREAST CANCERANTICANCER RESEARCH, 2004, 24 (5D) : 3445 - 3446Nilsson, S.Larsen, R. H.Bruland, O. S.
- [5] Alpha-particle emitting radium-223: A potential new treatment of skeletal metastases.JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 115P - 116PKim, YJLee, YSJeong, JMLee, DSChung, JKLee, MC
- [6] Phase I study of Alpharadin™ (223Ra), an alpha-emitting bone-seeking agent in cancer patients with skeletal metastasesEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S290Nilsson, SBalteskard, LFosså, SDWestlin, JEBruland, OSLarsen, RHBorch, KW
- [7] Bone-Seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223CURRENT ADVANCES IN OSTEOSARCOMA, 2014, 804 : 291 - 304Anderson, Peter M.Subbiah, VivekRohren, Eric
- [8] Alpha Particles as Radiopharmaceuticals in the Treatment of Bone Metastases: Mechanism of Action of Radium-223 Chloride (Alpharadin) and Radiation ProtectionONCOLOGY-NEW YORK, 2012, 26 (04): : 330 - 341Cheetham, Philippa J.Petrylak, Daniel P.
- [9] Phase I clinical trial exploring the alpha emitting radium-223 against skeletal metastases: blood clearance in patients with breast and prostate cancerINTERNATIONAL JOURNAL OF CANCER, 2002, : 285 - 285Larsen, RHBorch, KWAas, MFossaa, SDBalteskard, LTraasdahl, EHess, SSalberg, GHenriksen, GSchoultz, BWNilsson, SBruland, OS
- [10] First Danish experiences of Radium-223 treatment to patients with prostate cancer and bone metastases. Is it safe for the staff?EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S857 - S857Cortsen, A. K.Cortsen, A. K.